MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Estrogen and related hormone effects
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,795 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,795 works in the cohort · of 4,299,418page 26 of 36

Labels cover 7 of 1,795 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,795 of 1,795 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Fulvestrant for hormone-sensitive metastatic breast cancer
Clara I. Lee, Annabel Goodwin, Orit Freedman, Mark Clemons, Nicholas Wilcken
2014· reference-entry· en· Cochrane Database of Systematic Reviews· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
Anti-progestin therapy targets hallmarks of breast cancer risk
Bruno M. Simões, Robert Pedley, Curtis W. McCloskey, Matthew Roberts, Austin D. Reed, Alecia‐Jane Twigger +29 more
2025· article· en· Nature· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
Herbal Supplement PC-Spes for Prostate Cancer
Mário L de Lemos
2002· article· en· Annals of Pharmacotherapy· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
affno abstractunlabeled
Raloxifene: A Review
Loren D. Grossman
2000· review· en· Journal SOGC· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
4
citations
affno abstractunlabeled
Tamoxifen—when more might be better
Carlos Caldas, Ian F. Tannock
2013· review· en· Nature Reviews Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarkers in postmenopausal women with hormone receptor-positive locally advanced breast cancer
OC Freedman, Eitan Amir, George Dranitsaris, Mitch Dowsett, Dec Cole, Harriette Kahn +3 more
2009· article· en· Breast Cancer Research· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
3
citations
venueno affunlabeled
Effects of raloxifene treatment on the phenotype of blood monocytes
Karim Zouaoui Boudjeltia, Patrick Durez, Didier Oberweis, Michel Guillaume, Claude Remacle, P. Cauchie +4 more
2010· article· en· Canadian Journal of Physiology and Pharmacology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
3
citations
afffundaboutunlabeled
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole
Judith‐Anne W. Chapman, Jane Bayani, Sandip Sengupta, John M.S. Bartlett, Tammy Piper, Mary Anne Quintayo +20 more
2024· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · metaresearchconsensus · none
3
citations
affunlabeled
Oxidative metabolism of estrogens
Joyce Lewis
2011· article· en· cIRcle (University of British Columbia)· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
3
citations

How this was built: Screen · Findings · About